Testosterone Replacement Psychoanalysis for Men Gets a New Look <<>>

Written by pennmedicinenews on December 21, 2009 – 4:27 pm -

In continuing coverage, an article in the Bulwark Way Monthly describes the Testosterone Trials, led by Peter Snyder, MD, professor of Nostrum in Endocrinology. In contrast with women and estrogen, men don't lose out testosterone uniformly. "There's no puzzle that testosterone declines with age, but at this item we don't comprehend if the decline…is a typical curiosity or a pathological phenomenon," says Snyder. "There are passably men in their 90s who be enduring testosterone levels that are average for a man of 25 to achieve you miracle <<>>

Tags: ,
Posted in 2009, Pen Medicine, communications_placement, december, endocrinology, highlights, in-the-news, peter_snyder, research, urology, wall_street_journal | Comments Off

Hormone Boosts for Men Get a Try out <<>>

Written by pennmedicinenews on November 30, 2009 – 6:03 pm -

To upon if some of the debilities of senile men are due to low testosterone, the home rule is funding a jingoistic muse about to see whether older men with low testosterone help from boosting it, according to a front-page story in Sunday’s Philadelphia Inquirer. Led by University of Pennsylvania endocrinologist Peter Snyder, MD, professor of Medicine, the $45 million clinical trial, which this month began recruiting 800 men older than 64, is by far the largest for good to correspond the effects of the quintessential spear hormone with a placebo. It make research whether in some men, symptoms of aging such as ebbing energy, worn out libido, and muddy memory are partly due to testosterone deficiency. It is, Snyder said, an "unprecedented opportunity" to let fall pounce on the question: Is unusually low testosterone pathological, or well-deserved a regular part of aging? Additional coverage appeared in the Penn Almanac <<>>

Tags: ,
Posted in 2009, Pen Medicine, communications_placement, endocrinology, highlights, in-the-news, november, peter_snyder, philadelphia_inquirer, research | Comments Off

Lab Watch: Analyse Frontiers in Diabetes <<>>

Written by pennmedicinenews on November 19, 2009 – 3:44 pm -

Why do we eat? Rexford Ahima, MD, PhD, is dispiriting to solution that proposition beyond the shadow of a doubt by studying the hormones that fix voracity and desire. "Our basic experimentation at issue is how fat cells impart with the brain, liver and muscle," said Ahima, who directs the corpulence item of the University of Pennsylvania's Launch for Diabetes, Bulk and Metabolism. Disrupting these messages can reason overeating, portliness and diabetes. "Drugs targeting ghrelin are being developed," Ahima said. They may improve people who possess baffled their appetites - and a dangerous amount of worth - due to aging, cancer or infections. In a recent study, Ahima's mate Anne Cappola, MD, ScM, companion professor of Medicament in Endocrinology and Epidemiology, showed that frail anile women with unexplained slant sacrifice ate more after receiving ghrelin <<>>

Tags: ,
Posted in 2009, Pen Medicine, anne_r._cappola, communications_placement, endocrinology, epidemiology, highlights, idom, in-the-news, november, research, rex_ahima | Comments Off

Hormone Helps Frail Women Gain Weight <<>>

Written by pennmedicinenews on June 17, 2009 – 4:16 pm -

Scientists at the University of Pennsylvania originate that a hormone called ghrelin increased the appetite of frail older women, which could nick prevent ballast waste that can be a sliding screw in aging. Infusions of ghrelin helped women catch in more calories per refection fact absent-minded. These findings were presented by Anne Cappola, MD, ScM, assistant professor of Pharmaceutical in Endocrinology, Diabetes, and Metabolism and Carrie Burns, MD, assistant professor of clinical Cure-all in Endocrinology, Diabetes, and Metabolism at the Endocrine Society Annual Congregation in Washington, DC. Coverage from Reuters Robustness appears on The Doctor’s Channel and notes that women given ghrelin infusions in the analysis consumed 51% more calories after the ghrelin infusion than the placebo infusion, due to increased carbohydrate (p = 0.005) and protein (p = 0.04) intake, but not fat (p = 0.38) <<>>

Tags: ,
Posted in 2009, Pen Medicine, anne_r._cappola, carrie_burns, communications_placement, edom, endocrinology, highlights, in-the-news, june, research, reuters_health, ss0609, the_doctor's_channel | Comments Off
RSS